Intellia Therapeutics (NTLA) Stock Price

$8.73 6.2%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    4

  • Fundamental

    1

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Intellia Therapeutics, AI stock picks, stock alerts and much more.

Sign up

NTLA AI Stock Analysis

AI stock analysis for NTLA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Intellia Therapeutics (NTLA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Intellia Therapeutics (NTLA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Intellia Therapeutics (NTLA), currently trading at $8.73, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About NTLA

LSE

  • Intellia Therapeutics, Inc.

  • Symbol

    NTLA

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    903.7M

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $25.72
0.1%
5
INO Inovio Pharmaceuticals
INO		 $1.81
3.7%
2
MRNA Moderna
MRNA		 $33.85
0.9%
3
AVXL Anavex Life Sciences
AVXL		 $9.56
0.5%
5
BBIO BridgeBio Pharma
BBIO		 $36.74
1.3%
5

News

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Therapeutics, Inc. Lawsuit – NTLA

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Therapeutics, Inc. Lawsuit – NTLA
March 24, 2025. accessnewswire.com
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors – Contact Levi & Korsinsky

Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors – Contact Levi & Korsinsky
March 24, 2025. globenewswire.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Intellia Therapeutics, Inc.(NTLA) Shareholders

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Intellia Therapeutics, Inc.(NTLA) Shareholders
March 23, 2025. accessnewswire.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA
March 23, 2025. accessnewswire.com

NTLA Alternative Data

Web Traffic

Intellia Therapeutics receives an estimated 25098 monthly visitors to intelliatx.com.

  • Web Traffic

    25098

  • Change from Previous Month

    23.1%

  • 3 Month Change

    1.6%

  • YoY Change

    1.6%

News Mentions

Intellia Therapeutics was mentioned 4 times in the news yesterday.

  • News Mentions

    4

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    300%

Reddit Mentions

Intellia Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

Twitter Followers

Intellia Therapeutics has 11,445 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    11445

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.6%

  • YoY Change

    0.6%

Instagram Followers

Intellia Therapeutics has 1,259 Instagram Followers on its main Instagram account, up by 0.9% over the last month.

  • Instagram Followers

    1259

  • Daily Change

    0%

  • 1 Month Change

    0.9%

  • 3 Month Change

    1.5%

  • YoY Change

    1.5%

LinkedIn Followers

60,571 are following Intellia Therapeutics on LinkedIn, up by 0.7% over the last month.

  • LinkedIn Followers

    60571

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    2.9%

Job Postings

Intellia Therapeutics has an estimated 23 open job postings, which is down -8% over the last month.

  • Job Postings

    23

  • Daily Change

    0%

  • 1 Month Change

    8%

  • 3 Month Change

    228.6%

  • YoY Change

    228.6%

LinkedIn Employees

According to LinkedIn, Intellia Therapeutics has 511 employees, down by -1.5% over the last month.

  • LinkedIn Employees

    511

  • Daily Change

    0%

  • 1 Month Change

    1.5%

  • 3 Month Change

    14.4%

  • YoY Change

    14.4%

Business Outlook

According to employee reviews, the business outlook among employees at Intellia Therapeutics is 33 out of 100 (bearish).

  • Business Outlook

    33

  • Change from Previous Month

    17.5%

  • 3 Month Change

    0%

  • YoY Change

    0%

NTLA Financials

NTLA Key Metrics

  • Total Revenue

    $12.9M

  • Net Income

    -$128.9M

  • Earnings per Share

    -$1.3

  • Free cash flow

    -$86.2M

  • EBITDA

    -$133.9M

  • EBITDA Ratio

    -10.3993

  • Total Assets

    $1.2B

NTLA 2-year Revenue & Income
NTLA 2-year Free Cash Flow

NTLA Technicals

NTLA SMA
NTLA RSI

FAQ

What's the current price of Intellia Therapeutics (NTLA) Stock?
The price of an Intellia Therapeutics (NTLA) share is $8.73.

What's the market cap of Intellia Therapeutics?
The current market cap of Intellia Therapeutics is 903.7M.

Should I buy or sell NTLA?
Intellia Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Intellia Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Intellia Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Intellia Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Intellia Therapeutics (NTLA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Intellia Therapeutics stock right now, as the outlook appears bearish.

What are some stocks similar to Intellia Therapeutics (NTLA) that investors often compare it to?
Intellia Therapeutics (NTLA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Intellia Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Intellia Therapeutics' stock price to be around $7.97 in 2026. Starting from the current price of $8.73, this represents a 8.7% change in price, indicating a bearish outlook for the stock.

How to buy Intellia Therapeutics (NTLA) Stock?
Intellia Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Intellia Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.